Caligan Partners as of Dec. 31, 2024
Portfolio Holdings for Caligan Partners
Caligan Partners holds 14 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Liquidia Corporation Com New (LQDA) | 29.3 | $116M | 8.1M | 14.23 | |
| Verona Pharma Sponsored Ads (VRNA) | 16.9 | $67M | 1.4M | 46.44 | |
| Exelixis (EXEL) | 12.9 | $51M | 1.5M | 33.30 | |
| Evolus (EOLS) | 7.5 | $30M | 2.7M | 11.04 | |
| Anika Therapeutics (ANIK) | 6.0 | $24M | 1.4M | 16.46 | |
| BioCryst Pharmaceuticals (BCRX) | 5.7 | $23M | 3.0M | 7.52 | |
| Agios Pharmaceuticals (AGIO) | 5.2 | $21M | 626k | 32.86 | |
| Sage Therapeutics (SAGE) | 4.2 | $17M | 3.1M | 5.43 | |
| Y Mabs Therapeutics | 3.5 | $14M | 1.8M | 7.83 | |
| Mineralys Therapeutics (MLYS) | 3.2 | $12M | 1.0M | 12.31 | |
| Merus N V (MRUS) | 2.7 | $11M | 255k | 42.05 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.4 | $5.5M | 752k | 7.32 | |
| Verrica Pharmaceuticals | 1.3 | $5.2M | 7.4M | 0.70 | |
| Enanta Pharmaceuticals (ENTA) | 0.3 | $1.1M | 185k | 5.75 |
